Lexology July 28, 2024
Click here to listen the audio
On this episode of Ropes & Gray’s podcast series Controlling Opinions, hear from partners Brett Friedman, Andrew O’Connor, and Josh Oyster regarding recent developments related to the prescribing of controlled substances via telemedicine. They discuss the current DEA regulatory landscape related to prescriptions of controlled substances via telemedicine and explore the implications of a recently announced prosecution in which the Department of Justice alleged that executives at a digital health company wrongfully distributed controlled substances via telemedicine.
Transcript:
Josh Oyster: Hi, I’m Josh Oyster, a partner in the life sciences regulatory and compliance practice group in Ropes & Gray’s Washington, D.C. office. I’m excited to be with you today for this episode of Controlling...
Today's Sponsors
Today's Sponsor